Eagle Asset Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-315,520	Closed	-$6.77M	–	576
2023 Q4	$6.77M	Buy	315,520 +26,387	+9%	+$523K	0.04%	335
2023 Q3	$5.96M	Sell	289,133 -5,658	-2%	-$144K	0.04%	330
2023 Q2	$8.7M	Sell	294,791 -8,170	-3%	-$230K	0.05%	281
2023 Q1	$6.98M	Sell	302,961 -26,123	-8%	-$719K	0.04%	298
2022 Q4	$9.09M	Buy	329,084 +73,624	+29%	+$2.19M	0.06%	249
2022 Q3	$7.84M	Sell	255,460 -8,244	-3%	-$268K	0.05%	270
2022 Q2	$7.76M	Buy	263,704 +59,854	+29%	+$1.57M	0.05%	283
2022 Q1	$6.56M	Buy	203,850 +12,334	+6%	+$424K	0.03%	345
2021 Q4	$8.63M	Sell	191,516 -51,029	-21%	-$2.42M	0.04%	332
2021 Q3	$12.2M	Sell	242,545 -48,558	-17%	-$2.74M	0.06%	278
2021 Q2	$22.8M	Sell	291,103 -26,759	-8%	-$1.66M	0.1%	226
2021 Q1	$17.8M	Buy	317,862 +18,676	+6%	+$1.25M	0.08%	247
2020 Q4	$25.1M	Buy	+299,186	New	+$18.1M	0.14%	205